#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Acute liver failure


Authors: K. Maťašová
Authors‘ workplace: Neonatologická klinika, Jesseniova lekárska fakulta v Martine, Univerzita Komenského v Bratislave, Univerzitná nemocnica Martin
Published in: Čes-slov Neonat 2026; 32 (1): 5-10.
Category: Original Paper

Overview

Acute liver failure in the newborn is a serious condition with an unfavorable prognosis. It is usually the result of a disease that affects the liver during the fetal period and is defined as a loss of synthetic function of the liver with coagulopathy unresponsive to vitamin K administration and an INR ≥ 2.0. The most common causes of acute liver failure in the newborn are gestational alloimmune liver disease, viral infections, hemophagocytic lymphohistiocytosis, and inborn errors of metabolism, most often affecting mitochondria. The article provides an overview of the differential diagnosis and basic principles of treatment of the newborn with acute liver failure. The main cause of liver failure in newborns is gestational alloimmune liver disease, when hepatocyte development is impaired as a result of transplacental transfer of maternal antibodies. There are no specific serological tests for the diagnosis of this condition, nor is the antigen that induced the production of antibodies known. Early administration of intravenous immunoglobulin in combination with exchange transfusion reduces mortality. Prevention consists of administering intravenous immunoglobulin in subsequent pregnancies.

Keywords:

liver failure – newborn – GALD – koagulopathy


Sources

1. Conover KR, Saul S, Chapin CA, et al. Defining a histologic scoring system for gestational alloimmune liver disease. Am J Surg Pathol 2025; 49(12): 1326-1333. Dostupné z: https://doi. org/10.1097/PAS.0000000000002454.

2. Di Giorgio A, Bartolini E, Calvo PL, et al. Diagnostic approach to acute liver failure in children: a position paper by The SIGENP Liver Disease Working Group. Dig Liver Dis 2021; 53(5): 545–557. Dostupné z: https://doi.org/10.1016/j.dld.2021.03.004.

3. Gabrysch CH, Dressler-Steinbach I, Verlohren S, et al. Maternal immunoglobulin treatment of gestational alloimmune liver disease to prevent neonatal liver failure: a single center case series. Transfus Med Hemother 2025; 52(6): 368–378. Dostupné z: https://doi.org/10.1159/000548476.

4. Helali N, Gagnon H, Álvarez F. Gestational alloimmune liver disease reconsidered: advocating for a new nomenclature and enhanced diagnosis accuracy. World J Clin Pediatr 2025; 14(4): 106219. Dostupné z: https://doi.org/10.5409/wjcp.v14. i4.106219.

5. Henter JI, Horne A, Aricó M, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007; 48(2): 124–131. Dostupné z: https://doi.org/10.1002/pbc.21039.

6. Kanungo S, Morton J, Neelakantan M, et al. Mitochondrial disorders. Ann Transl Med 2018; 6(24): 475. Dostupné z: https:// doi.org/10.21037/atm.2018.12.13.

7. Karadağ N, Okbay Güneş A, Karatekin G. Acute liver failure in newborns. Turk Arch Pediatr 2021; 56(2): 108–114. Dostupné z: https://doi.org/10.5152/TurkArchPediatr.2021.190205.

8. Kelgeri C, Kanthimathinathan HK, Couper M, et al. Etiology, characteristics, and outcomes of neonatal liver failure: lessons learned over the last 3 decades. J Pediatr 2024; 275 : 114245. Dostupné z: https://doi.org/10.1016/j.jpeds.2024.114245.

9. Konkol S, Killeen RB, Rai M. Hemophagocytic Lymphohistiocytosis. Online. Aktualizováno 2025 May 3. In: StatPearls. Treasure Island (FL): StatPearls Publishing 2026. Dostupné z: https:// www.ncbi.nlm.nih.gov/books/NBK557776/.

10. Larson-Nath C, Vitola BE. Neonatal acute liver failure. Clin Perinatol 2020; 47(1): 25–39. Dostupné z: https://doi.org/10.1016/j. clp.2019.10.006.

11. Murrieta-Coxca JM, Aengenheister L, Schmidt A, et al. Addressing microchimerism in pregnancy by ex vivo human placenta perfusion. Placenta 2022; 117 : 78–86. Dostupné z: https:// doi.org/10.1016/j.placenta.2021.10.004.

12. Rieneck K, Rasmussen KK, Schoof EM, et al. Hunting for the elusive target antigen in gestational alloimmune liver disease (GALD). PLoS One 2023; 18(10): e0286432. Dostupné z: https:// doi.org/10.1371/journal.pone.0286432.

13. Taylor SA, Whitington PF. Neonatal acute liver failure. Liver Transpl 2016; 22(5): 677–685. Dostupné z: https://doi. org/10.1002/lt.24433.

14. Whitington PF, Kelly S, Taylor SA, et al. Antenatal treatment with intravenous immunoglobulin to prevent gestational alloimmune liver disease: comparative effectiveness of 14-week versus 18-week initiation. Fetal Diagn Ther 2018; 43(3): 218–225. Dostupné z: https://doi.org/10.1159/000477616.

15. Zermano S, Novak A, Vogrig E, et al. GALD: new diagnostic tip for early diagnosis –⁠ a case report and literature review. Front Reprod Health 2023; 5 : 1077304. Dostupné z: https://doi. org/10.3389/frph.2023.1077304.

Labels
Neonatology Neonatal Nurse
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#